To establish whether FLT3-ITD activity and STAT5 modulate CDC25A transcription, we performed chromatin-immunoprecipitation (ChIP) experiments on MOLM-14 or MV4-11 AML cells treated with an FLT3 inhibitor. This evidence concerns the gene FLT3 and acute myeloid leukemia.